The present invention relates to new bisbenzisoselenazolonyl derivatives
of the following general formula (I), wherein R is C.sub.4-5-alkylene,
and their pharmaceutically acceptable salts. The inventive derivatives
have antineoplastic, anti-inflammatory and antithrombotic activities.
##STR00001##